PTC Therapeutics | Efectivo Y Equivalentes



Cash And Equivalent Cambio Fecha
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
Amgen USD 8.81B 3.16B 2025-03
Biogen USD 2.6B 223.3M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Cytokinetics USD 94.86M 47.97M 2024-12
Daiichi Sankyo JPY 639.84B 42.31B 2025-03
Gilead Sciences USD 7.93B 2.06B 2025-03
Incyte USD 2.41B 720.83M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Ironwood Pharmaceuticals USD 88.56M 348K 2024-12
Novartis USD 8.87B 4.74B 2024-12
Pfizer USD 1.43B 387M 2025-03
PTC Therapeutics USD 779.71M 253.71M 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
TG Therapeutics USD 179.89M 15.93M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Xencor USD 40.88M 11.84M 2024-12



PTC Therapeutics Efectivo Y Equivalentes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.